Selected article for: "novel coronavirus and virus contain"
Author: Iyer, Mahalaxmi; Jayaramayya, Kaavya; Subramaniam, Mohana Devi; Lee, Soo Bin; Dayem, Ahmed Abdal; Cho, Ssang-Goo; Vellingiri, Balachandar
Title: COVID-19: an update on diagnostic and therapeutic approaches
  • Cord-id: bisheysk
  • Document date: 2020_4_30
    • ID: bisheysk
    Snippet: The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide. COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease. In such a pandemic situation, various steps have been taken by the government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This pandemic situation has forced scientists to rework strategies to com
    Document: The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide. COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease. In such a pandemic situation, various steps have been taken by the government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures. COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by an inappropriate immune reaction. Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective. As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP). More research is required for further understanding of the influence of diagnostics and therapeutic approaches to develop vaccines and drugs for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • abnormal increase and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal increase and liver damage: 1
    • abnormal increase and liver kidney: 1
    • abnormal increase and lymphocyte count: 1, 2
    • abnormal procalcitonin and acute ards respiratory distress syndrome: 1
    • abnormal procalcitonin and acute respiratory syndrome: 1, 2, 3, 4
    • abnormal procalcitonin and lymphocyte count: 1, 2, 3, 4, 5
    • abnormal procalcitonin and lymphocyte level: 1, 2
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • absence presence and additional assay: 1
    • absence presence and liver damage: 1, 2
    • absence presence and liver kidney: 1, 2
    • absence presence and liver lung: 1
    • absence presence and local state: 1
    • absence presence and lopinavir ritonavir: 1, 2